dose dose escalation

Related by string. * DO Se . DOSE . Dose : mg kg dose . dose escalation study . priming doses . single ascending dose . milligram dose / Doses . DOSES . doses : tolerated dose MTD . multiple ascending dose . mg dose . mg doses . milligram doses / escalations . Escalations . ESCALATION . Escalation : label dose escalation . dose escalation . dose escalation trial . dose escalation clinical * *

Related by context. Frequent words. (Click for all words.) 71 dose escalation study 69 blind randomized 68 blind randomized placebo 68 dose escalation trial 68 label dose escalation 67 blinded placebo controlled 67 randomized Phase III 67 multiple ascending dose 67 Phase Ib 66 randomized 66 placebo controlled 66 single ascending dose 66 randomized placebo controlled 66 dose cohorts 65 safety tolerability pharmacokinetics 65 randomized #:# 65 dose regimens 65 Phase 1b clinical 64 multicentre 64 phase IIb 64 Phase 2a trial 64 dose escalation 64 Phase 1b 64 phase 2a 64 phase IIa 63 randomized controlled 63 Phase 2b trial 63 multicenter 63 Phase 2b study 63 Phase 2a clinical 63 double blind placebo 62 randomized clinical 62 pharmacodynamics 62 multicenter randomized double 62 blind placebo controlled 61 dose regimen 61 multicenter clinical 61 Phase IIa trial 61 prospective randomized 61 RG# [001] 61 Phase IIa 61 nitazoxanide 60 NRTI 60 adalimumab 60 Phase IIb trial 60 biologic therapy 60 relapsed multiple myeloma 60 randomized double 60 sunitinib 60 BAY #-# 60 mcg kg 60 confirmatory Phase III 59 Phase 2a 59 unblinded 59 Phase 2b clinical 59 randomized controlled clinical 59 Phase IIa clinical 59 HGS ETR1 59 refractory multiple myeloma 59 mg BID 59 peginterferon alfa 2b 58 metastatic renal cell carcinoma 58 Phase 2b 58 safety tolerability 58 peginterferon alfa 2a 58 ofatumumab 58 plus ribavirin 58 mg dose 58 azacitidine 58 subcutaneous injections 58 randomized Phase 58 Amigal 58 relapsing remitting multiple sclerosis 58 multicenter study 58 evaluable patients 58 decitabine 58 methylnaltrexone 58 systemic lupus erythematosus SLE 58 Phase IIb clinical 58 pegylated interferon 58 ISENTRESS 58 FOLFIRI 58 valopicitabine 58 TELCYTA 57 HCV infected 57 hepatocellular carcinoma HCC 57 Board DSMB 57 dosing regimens 57 pivotal Phase III 57 tolerated dose MTD 57 Phase III clinical 57 SUTENT 57 lacosamide 57 investigational oral 57 PF # [001] 57 placebo controlled trials 57 events SAEs 57 imetelstat 57 sitagliptin 57 FOLFOX 57 vicriviroc

Back to home page